TopFunds

Drug Manufacturers General

Companies

11 companies

LIST VIEW

11 companies
Valuation
Historical Performance:
Fundamentals
Sort by:
01
Eli Lilly And Co LLY

1,152.7 (-0.6)%

38.7
1.9%
-
-
-
18.4%
77.8%

1.6

02
Johnson & Johnson JNJ

276.7 (+0.5)%

32.1
2.8%
-
-
-
13.5%
32.9%

1.2

03
AbbVie Inc. ABBV

259.7 (-0.8)%

73.2
4.3%
-
-
-
3.2%
(130.9)%

3.3

04
Merck & Co., Inc. MRK

150.3 (-0.9)%

120.2
4.3%
-
-
-
13.3%
34.7%

2.4

05
Amgen Inc. AMGN

442.4 (-0.1)%

27.5
4.2%
-
-
-
8.5%
89.1%

3.5

06
Novo Nordisk A/S NVO

46.7 (-0.1)%

11.5
3.7%
-
-
-
18.9%
52.8%

0.7

07
Gilead Sciences, Inc. GILD

149.5 (-0)%

(56)
7.1%
-
-
-
14.4%
37.6%

1.7

08
Pfizer Inc. PFE

28.6 (-1.3)%

37.8
6.7%
-
-
-
3.7%
9%

4.6

09
Bristol-Myers Squibb Company BMY

67.4 (-0.3)%

14.9
8.3%
-
-
-
7.8%
38.1%

2.7

10
Biogen BIIB

223.8 (+0.5)%

39.6
9%
-
-
-
4.4%
7.1%

2.5

11
Zoetis ZTS

75 (-1.5)%

12.4
7.3%
-
-
-
17.3%
80.3%

2.7

Total
Help

Assumes equal weights for the Base and Lens views. The Holdings view is position-weighted.

(-0.4)%
32
5.4%
252.5%
0%
0%
11.2%
29.8%
2.4